Robert Fallstrom
Family Medicine · Yakima, WANPI 1922033604
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 235 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AstraZeneca at 27.1% of the total. Reporting peaked in 2019 at $1,782 and has fallen 99.0% since, to $18 in 2024. Among family medicine clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 235 payments — averaging $18.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Johnson & Johnson$445
- Boehringer Ingelheim$427
- Pfizer$420
- Novo Nordisk$342
- Lilly USA, LLC$332
- plus $1K from 23 others
What the payments were for
- Food & beverage$4,25499%
- Education$60%
- Other$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 46 | $1,161 |
| Johnson & Johnson(2 entities) | 22 | $445 |
| Boehringer Ingelheim | 23 | $427 |
| Pfizer | 32 | $420 |
| Novo Nordisk | 26 | $342 |
| Lilly USA, LLC | 19 | $332 |
| GSK | 12 | $230 |
| Sanofi-aventis U.S. LLC | 9 | $169 |
| AbbVie | 11 | $138 |
| Amgen | 6 | $103 |
| Mylan Specialty L.p. | 4 | $91 |
| Merck | 4 | $58 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $50 |
| Biohaven Pharmaceuticals, Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Abbott | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $22 |
| Sunovion Pharmaceuticals Inc. | 1 | $21 |
| Grifols USA, LLC | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Baxter Healthcare | 1 | $18 |
| Phadia US Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Novartis | 1 | $17 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$244
- SYMBICORT$119
- BREZTRI AEROSPHERE$119
How this compares
$4,278 in reported general payments places this provider in the 90th percentile of 2,275 family medicine providers in Washington.
Other family medicine in Yakima
- Theodore VyeYakima$17K
- Portia JonesYakima$16K
- Vani BremjitYakima$14K
- John LyzanchukYakima$11K
- Roy GondoYakima$10K
- Kevin HatfieldSeattle$527K
- Marta KazymyraBlaine$222K
- Donella YoungDavenport$175K
- Robert McIntyreSeattle$107K
- James MorenBellingham$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.